IBN Sina Pharmaceutical Industry Ltd's profit jumped nearly 24 per cent in the financial year that ended on June 30.

Consolidated earnings per share stood at Tk 19.39 in the year, up from Tk 15.66 a year ago, said the company in a filing on the Dhaka Stock Exchange today.

Consolidated net asset value per share was Tk 83.36 and consolidated net operating cash flow per share was Tk 13.40 in 2021-22, compared to Tk 68.69 and Tk 17.67, respectively, in the previous financial year.

The board of directors recommended a 60 per cent cash dividend for the financial year.

The board also decided to transfer a part of the net assets aggregated value of Tk 20.81 crore of the Natural Medicine Division to its subsidiary IBN SINA Natural Medicine Ltd for better management and to make easy the operation of the natural medicine production and businesses.

Shares of IBN Sina Pharmaceutical closed 2.51 per cent higher at Tk 310 on the DSE today.